Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Sub-Clinical Bacteriuria in Pregnancy
NCT03275623Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nitrofurantoin, cefalexin and amoxicillin in Bacteriuria (2 arms), sponsored by UTHealth Houston. Primary endpoints: Number of Participants Who Have Cystitis at 10 months and Number of Participants Who Have Pyelonephritis at 10 months. Started Sep 2017; status: completed.
02
Drugs
nitrofurantoincefalexinamoxicillin
03
Conditions
Bacteriuria
Beyond the preview
Go deeper on NCT03275623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03275623.